EcoDrugPlus

Trace Amine-Associated Receptor 7d-Like

Ensembl ID : ENSNBRG00000016791
Gene Symbol: LOC102786096
2 Cross references
121 Possible Orthologues:

Transcription Factor P65-Like

Ensembl ID : ENSNBRG00000019689
Gene Symbol: LOC102785378
3 Cross references
198 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1-Like

Ensembl ID : ENSNBRG00000023744
Gene Symbol: LOC102799883
3 Cross references
200 Possible Orthologues:

Trifunctional Purine Biosynthetic Protein Adenosine-3-Like

Ensembl ID : ENSNBRG00000003935
Gene Symbol: LOC102790949
3 Cross references
246 Possible Orthologues:

Tryptophan 5-Hydroxylase-Like

Ensembl ID : ENSNBRG00000013478
Gene Symbol: LOC102776000
3 Cross references
207 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSNBRG00000001647
Gene Symbol: TPH1
1 Cross references
176 Possible Orthologues:

Tubulin Alpha 1c

Ensembl ID : ENSNBRG00000004072
Gene Symbol: TUBA1C
4 Cross references
185 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSNBRG00000001954
Gene Symbol: TUBA4A
1 Cross references
109 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSNBRG00000016160
Gene Symbol: LOC102795669
2 Cross references
169 Possible Orthologues:

Tubulin Alpha-1a Chain-Like

Ensembl ID : ENSNBRG00000000654
Gene Symbol: LOC102775910
2 Cross references
186 Possible Orthologues:

Tubulin Beta-1 Chain-Like

Ensembl ID : ENSNBRG00000005022
Gene Symbol: LOC102788202
2 Cross references
183 Possible Orthologues:

Tubulin Beta-2a Chain-Like

Ensembl ID : ENSNBRG00000013503
Gene Symbol: LOC102786948
2 Cross references
252 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).